Evidence map

ReviewMetabolic brain disease2025

A second act for spironolactone: cognitive benefits in renal dysfunction - a critical review.

Akhil Sharma et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40299184